-transparent.png){kind=logo}
Zotepine, a new tricyclic compound, was investigated in 20 schizophrenic patients in two different dosage groups. Group I (n = 8) received Zotepine in a high dosage of 270 mg +/- 37 mg/die. The other group (group II; n = 12) received a low dosage of 168 mg +/- 15 mg/die. In both groups 2 patients dropped out before the end of the treatment period because of clinical deterioration. In both groups, Zotepine manifested a rapid antipsychotic effect, good tolerability, and sedative properties during the initial days. Additionally there was a stronger positive influence on negative symptoms in the group with low dosage treatment.
Related Publications
D M Dieterle, and
M Ackenheil, and
F Müller-Spahn, and
H P Kapfhammer
February 1987,
Pharmacopsychiatry,
D M Dieterle, and
M Ackenheil, and
F Müller-Spahn, and
H P Kapfhammer
February 1987,
Pharmacopsychiatry,
D M Dieterle, and
M Ackenheil, and
F Müller-Spahn, and
H P Kapfhammer
October 2011,
Journal of clinical psychopharmacology,
D M Dieterle, and
M Ackenheil, and
F Müller-Spahn, and
H P Kapfhammer
February 1987,
Pharmacopsychiatry,
D M Dieterle, and
M Ackenheil, and
F Müller-Spahn, and
H P Kapfhammer
January 1979,
Arzneimittel-Forschung,
D M Dieterle, and
M Ackenheil, and
F Müller-Spahn, and
H P Kapfhammer
February 1987,
Pharmacopsychiatry,
D M Dieterle, and
M Ackenheil, and
F Müller-Spahn, and
H P Kapfhammer
June 1982,
Japanese journal of pharmacology,
D M Dieterle, and
M Ackenheil, and
F Müller-Spahn, and
H P Kapfhammer
February 1996,
Journal of pharmaceutical and biomedical analysis,
D M Dieterle, and
M Ackenheil, and
F Müller-Spahn, and
H P Kapfhammer
January 1979,
Arzneimittel-Forschung,
D M Dieterle, and
M Ackenheil, and
F Müller-Spahn, and
H P Kapfhammer
June 1993,
Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology,
